Bank of Montreal
LUCD icon

Bank of Montreal’s Lucid Diagnostics LUCD Stock Holding History

Bank of Montreal’s Portfolio LUCD Stock Details LUCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$328K Buy
285,236
+270,990
+1,902% +$345K ﹤0.01% 2617
2025
Q4 		$87.2K Hold
14,246
– – ﹤0.01% 3087
2025
Q3 		$14.4K Buy
+14,246
New +$15.6K ﹤0.01% 3324
2022
Q3 		– Sell
-15,524
Closed -$35 – 4270
2022
Q2 		$35 Buy
+15,524
New +$34.5K ﹤0.01% 3681

Other funds holding LUCD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Bank of Montreal's LUCD Position: Q1 2026 in Review

Bank of Montreal increased its Lucid Diagnostics (LUCD) stake by 1,902% in Q1 2026, buying an estimated $345K and bringing the position to 285,236 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #2617.

Bank of Montreal first reported a position in LUCD in Q2 2022 and has held it in 4 quarters since. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Bank of Montreal held 285,236 shares of Lucid Diagnostics worth $328K as of Q1 2026.
  • Bank of Montreal bought 270,990 Lucid Diagnostics shares in Q1 2026, an estimated $345K.
  • Lucid Diagnostics made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2617 holding.
  • Bank of Montreal first reported a position in Lucid Diagnostics in Q2 2022 and has held it in 4 quarters since.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.